Correction to "1-[5-(2-Fluorophenyl)-1-(Pyridin-3-Ylsulfonyl)-1h-Pyrrol-3-Yl]-N-Methylmethanamine Monofumarate (TAK-438), a Novel and Potent Potassium-Competitive Acid Blocker for the Treatment of Acid-Related Diseases."

Journal of Pharmacology and Experimental Therapeutics - United States
doi 10.1124/jpet.115.170120err
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)


Related search